Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04694027Phase 4Unknown
Phase 4, randomised, open-label trial (3 arms), sponsored by Cairo University. Primary endpoint: Improvement of pain severity at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04694027.